Search

everythinglearnresearchcommunity

for

Search:↓

Abolishing medical indication patents could hinder innovation in medicine.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

Patents don't guarantee money; inventors must work hard and stay involved.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

Australian court ruled that Bickfords did not infringe on Monster Energy's trade mark because Monster was not sold or known in Australia at the time.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Rosemary is valuable for its health benefits and uses in medicine, cosmetics, and food.

Microemulsions and nanoemulsions can effectively deliver drugs through the skin, but more research is needed to understand their differences and mechanisms.

Some herbal treatments are effective for skin disorders, but more research and regulation are needed.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Women inventors focus more on women's health, but there are few of them.

The document reviews patents on nanoparticle systems used to deliver drugs, discussing their creation, use in treatments, and commercial applications.

The UK Intellectual Property Office allows granting of supplementary protection certificates with negative terms.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

Natural organic cosmetics with high natural content and patent labeling are popular and profitable in the US market.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

3D skin bioprinting, using skin bioinks like collagen and gelatin, is growing fast and could help treat wounds, burns, and skin cancers, as well as test cosmetics and drugs.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Different crystal forms of drugs can change their effectiveness.